Stroke Rehabilitation Market will surpass US$ 679.6 Mn revenues towards the end of 2032

Stroke Rehabilitation Market 2022

The global stroke rehabilitation market was valued at US$ 266.4 Mn in 2021, and is expected to grow 2.4X by 2032. The stroke rehabilitation industry is set to witness a high growth rate of 9% and be valued at US$ 679.6 Mn by 2032.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/33088

Researchers are exploring recovery and rehabilitation treatments, which can have a time window of days, weeks, or months after a stroke, in parallel with efforts to improve acute stroke therapy. Therapies aimed at maximizing function in brain areas that survive a stroke or compensatory techniques to increase overall function are utilized to attain this goal.

With recorded sales of US$ 266.4 Mn in 2021, the global stroke rehabilitation market is predicted to experience high growth over the years ahead, owing to high product adoption globally. Demand for stroke rehabilitation is estimated to surge at a CAGR of 9% from 2022 to 2032.

Rehabilitation has been shown to help people recover from strokes. Repetitive, task-specific practices with performance feedback, often provided by rehabilitation specialists, improves the recovery of specific capabilities such as walking and upper-limb movements.

Majority of stroke victims survive the initial event, but they continue to live with considerable disability for years. In the United States alone, there are over 6 million stroke survivors. As a result, research into medicines that improve the quality of life of stroke patients in the chronic phase is crucial. Several studies have found that constraint-induced treatment, locomotor training, fluoxetine, and LDOPA, all offer considerable benefits in this area. Widespread adoption, on the other hand, remains elusive, and recent negative studies highlight the need for a deeper understanding of recovery/rehabilitation and its management.

In order to increase the intensity, repetitions, specificity, and feedback during the stroke rehabilitation process, the use of technological devices is essential. Some medical devices such as electrical stimulators, robotic stimulators, wireless stimulators, non-invasive stimulators, cognitive stimulators, and others can be used in the rehabilitation of post-stroke patients. Key market players are working on developing new rehabilitation devices that can help the stroke rehabilitation market grow.

MicroTransponder has developed the Vivistim Paired VNS system, a drug-free rehabilitation solution for patients associated with ischemic stroke. It received approval in August 2021.

Company Profiles:

Penumbra, Inc. (REAL System)
Saebo Inc
Shanghai Siyi Intelligent Technology Co., Ltd.
DJO Global
Shenzhen XFT Medical
Soterix Medical Inc.
Restorative Therapies
Zynex Medical, Inc
MYOLYN
ACP - Accelerated Care Plus.
Neurosoft
BIONIC Inc.
EB Neuro S.p.A.
Motorics Medical
Ottobock
Guangzhou Longest Science & Technology Co., Ltd.
Roceso Technologies Pte Ltd
Brain Stimulation AB

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/33088

Key Takeaways from Market Study

Electrical stimulators are more widely used than robotic stimulators, wireless stimulators, non-invasive stimulators, cognitive stimulators, and others in terms of volume. The segment held 70.6% value market share in 2021.

By stroke, ischemic strokes accounted for a market share of around 85.9% in 2021.

Hospitals and rehabilitation centers are focused on the rehabilitation of post-stroke patients. These segments together held a high market share of 53.9% in 2021.

The North America stroke rehabilitation market accounted for 34.4% of the global market share in 2021. This is due to the presence of key players in this region.

"Rising number of specialists for stroke rehabilitation, high prevalence of stroke, and increasing adoption of technology-based rehabilitation will drive demand growth of stroke rehabilitation over the coming years," says an analyst of Persistence Market Research.

Market Competition

Key suppliers of rehabilitation devices are focused on strategic collaborations and acquisitions to increase their market share value. Furthermore, throughout the ongoing pandemic, persistent demand for various treatments and devices is projected to benefit top corporations.

Market expansion is being fuelled by rising demand for home care settings, high demand for early diagnosis, and rising use of precision medicine.

In April 2022, Fesia Technology Company signed a distribution agreement with Chinesport Physiotherapy Company for the products Fesia Grasp and Fesia Walk.
In April 2021, DJO global completed the acquisition of MedShape, Inc., a privately-held medical device manufacturing company.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/33088

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the stroke rehabilitation market in its latest study, presenting a historical demand assessment of 2012 - 2021 and projections for 2022 - 2032.

The research study is based on the product (electrical stimulators [tabletop, wearable], robotic stimulators, wireless stimulators, non-invasive stimulators, cognitive stimulators, and others), stroke (ischemic stroke, hemorrhagic stroke, and transient ischemic stroke), and end user (hospitals, speciality clinics, ambulatory surgical centers, long-term treatment centers, home care settings, and rehabilitation centers), across seven key regions of the world.

Related Reports:

Anticancer Drugs Market - https://www.persistencemarketresearch.com/market-research/anticancer-drugs-market.asp

Anticancer Drugs Market is estimated to reach a whopping valuation of US$ 227 Bn by the end of 2026, up from just under US$ 129 Bn in 2018. This is indicative of a growth rate of 7.4% during the period from 2018 to 2026.

Contact us:

Persistence Market Research          
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About us: 

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.